We recently showed that phosphoinositide-3-kinase-␥-deficient (PI3K␥ Ϫ/Ϫ ) mice have increased cardiac contractility without changes in heart size compared with control mice (ie, PI3K␥ ϩ/ϩ or PI3K␥ ϩ/Ϫ ). In this study, we show that PI3K␥ Ϫ/Ϫ cardiomyocytes have elevated Ca 2ϩ transient amplitudes with abbreviated decay kinetics compared with control under field-stimulation and voltage-clamp conditions. When Ca 2ϩ transients were eliminated with high Ca 2ϩ buffering, L-type Ca 2ϩ currents (I Ca,L ), K ϩ currents, and action potential duration (APD) were not different between the groups, whereas, in the presence of Ca 2ϩ transients, Ca 2ϩ -dependent phase of I Ca,L inactivation was abbreviated and APD at 90% repolarization was prolonged in PI3K␥ Ϫ/Ϫ mice. Excitation-contraction coupling (ECC) gain, sarcoplasmic reticulum (SR) Ca 2ϩ load, and SR Ca 2ϩ release fluxes measured as Ca 2ϩ spikes, were also increased in PI3K␥ Ϫ/Ϫ cardiomyocytes without detectable changes in Ca 2ϩ spikes kinetics. The cAMP inhibitor Rp-cAMP eliminated enhanced ECC and SR Ca 2ϩ load in PI3K␥ Ϫ/Ϫ without effects in control myocytes. On the other hand, the ␤-adrenergic receptor agonist isoproterenol increased I Ca,L and Ca 2ϩ transient equally by Ϸ2-fold in both PI3K␥ Ϫ/Ϫ and PI3K␥ ϩ/Ϫ cardiomyocytes. Our results establish that PI3K␥ reduces cardiac contractility in a highly compartmentalized manner by inhibiting cAMP-mediated SR Ca 2ϩ loading without directly affecting other major modulators of ECC, such as AP and
A ctivation of PhosphoInositide-3 Kinases (PI3Ks) 1 enhances cell survival, proliferation, motility, migration, and secretion, while also regulating cytoskeletal structure and Ca 2ϩ signaling. [1] [2] [3] Genes encoding PI3Ks are divided into 3 major classes (I, II, and III). 4 Class I PI3Ks are expressed in the heart and convert phosphatidylinositol-4,5-bis-phosphate (PIP 2 ) to phosphatidylinositol-3,4,5-tri-phosphate (PIP 3 ), which acts as a second messenger by recruiting effectors with pleckstrin homology domains. 1, 4 Class I PI3Ks are categorized into class I A PI3Ks, which are typically activated by receptor tyrosine kinases (PI3K␣ and PI3K␤ in heart) and class I B PI3Ks (PI3K␥), which are primarily activated by G␤␥ subunits of G proteins. 4, 5 Selective inhibition of PI3Ks has been shown to potentiate ␤2-adrenergic-mediated enhancement of phospholamban (PLN) phosphorylation, contractility, and relaxation in adult rat ventricular cardiomyocytes. 6 Consistent with these studies, elimination of PI3K␥ in mice increases myocardial contractility as well as basal cAMP levels [7] [8] [9] and PLN phosphorylation. 8, 9 Moreover, cardiacspecific elimination of PTEN (phosphatase and tensin homo-logue deleted on chromosome 10), a lipid phosphatase that dephosphorylates PIP 3 to PIP 2 , decreases contractility which is prevented by simultaneous ablation of PI3K␥. 8 More recently, PI3K␥ was shown to regulate cardiomyocyte contractility by direct activation of a cAMP-degrading phosphodiesterase (PDE3B) in a kinase independent PI3K␥ manner. 9 PI3K␥ also appears to be important in heart disease. For example, in mice subjected to aortic banding, PI3K␥ activity increases as cardiac function deteriorates, 9, 10 whereas PI3K inhibition 7 or loss of PI3K␥ kinase activity 9 partially prevents impaired heart function. Moreover, PI3K␥ ablation protects hearts from the detrimental effects of chronic ␤-adrenergic 11 and platelet-activating factor 12 stimulation. The importance of PI3K␥ in pathogenesis of heart disease is further supported by the observation that suppression of Gq signaling, 13 in pressure-overload mice, prevents the transition to heart failure while blocking activation of PI3K␥.
The aim of this study was to elucidate the cellular mechanism(s) responsible for the enhanced cardiac contractility in mice lacking PI3K␥. Our studies reveal that PI3K␥ elimina-tion increases Ca 2ϩ transient amplitude and enhances the efficiency of excitation-contraction coupling (ECC) as a consequence of elevating SR Ca 2ϩ content via a cAMPdependent pathway without affecting L-type Ca 2ϩ current (I Ca,L ) or action potential (AP) profile.
Materials and Methods
The generation of PI3K␥ ϩ/ϩ , PI3K␥ ϩ/Ϫ , and PI3K␥ Ϫ/Ϫ mice has previously been described. 14 All experiments were performed in accordance with the Canadian Council of Animal Care.
Myocyte Isolation and Measurement of Contractility, Ca 2؉ Transients, and Ca 2؉ Spikes
Ventricular cardiomyocytes were isolated as previously described 15 (see online supplement, available at http://circres.ahajournals.org). For contractility and Ca 2ϩ transients the bath solutions contained (in mmol/L) 140 NaCl, 4 KCl, 1 MgCl 2 , 1.2 CaCl 2 , and 10 HEPES (pHϭ7.4, NaOH). Contractility was estimated using cell shortening, whereas Ca 2ϩ transients were estimated using indo-1,AM 8, 9 (see online supplement).
In voltage-clamped studies, cardiomyocytes were loaded with fluo-3 or fluo-5N plus EGTA to record Ca 2ϩ transients or Ca 2ϩ spikes, respectively. For Ca 2ϩ spikes recordings, cardiomyocytes were exciting at 488 nm and the emitted fluorescence at 515 nm was recorded using line-scan mode (IX50, Fluoview, Olympus) as described. 16 The pipette solution contained (in mmol/L) 140 KCl, 5 NaCl, 1 MgCl 2 , 7 Mg-ATP, 10 HEPES, 10 D-glucose, 0.75 fluo-5N, 4 EGTA, and 1.55 CaCl 2 ([Ca 2ϩ ] i ϭ75 nmol/L; pHϭ7.2 with KOH). Fluorescence signals and I Ca,L were simultaneously recorded at sampling rates of 10 kHz using voltage protocols and solutions as described (see online supplement). 17
Electrophysiological Recordings and SR Ca 2؉ Content
APs and I Ca,L were measured with whole-cell patch-clamp technique 18 under current-and voltage-clamp mode, respectively (see online supplement for protocols). For the APs, the pipette solution contained (in mmol/L) 120 K ϩ -aspartate, 20 KCl, 1 MgCl 2 , 5 NaCl, 5 Mg-ATP, and 10 HEPES (pH set to 7.2 with KOH). I Ca,L was elicited simultaneously to Ca 2ϩ transient. In this case, the recording bath solution contained (in mmol/L) 140 NaCl, 0.5 MgCl 2 , 5 CsCl, 5.5 glucose, 5 HEPES, and 1.8 CaCl 2 (pHϭ7.4, NaOH), whereas the pipette solution contained (in mmol/L) 130 CsCl, 1 MgCl 2 , 1 NaH 2 PO 4 , 3.6 Na 2 -phosphocreatine, 2 KCl, 5 MgATP, 0.05 fluo-3 pentapotassium salt, and 10 HEPES (pHϭ7.2, CsOH).
SR Ca 2ϩ content was estimated by integrating the Na ϩ -Ca 2ϩ exchanger current (I NCX ) 19 induced by brief (10 s) applications of 20 mmol/L caffeine after SR loading protocols involving 8 100-ms depolarizing steps from Ϫ80 to ϩ10 mV (1 Hz). The pipette solution contained (in mmol/L) 125 K ϩ -aspartate, 20 KCl, 0.5 MgCl 2 , 5.0 Na 2 -phosphocreatine, 0.4 Na ϩ -GTP, 7 MgATP, 0.05 fluo-3, and 10 HEPES, (pHϭ7.2, KOH) (see online supplement).
Statistics
To test for significance between groups we used either a one-way analysis of variance (ANOVA) followed by the Student Neuman-Keuls test or the Kruskal-Wallis test followed by an unpaired t test when the data were nonparametric or paired t tests when comparing results from the same cardiomyocyte. PϽ0.05 was considered statistically significant (SPSS). Data are presented as meanϮSEM.
Results

Contractility, Ca 2؉ Transients, I Ca,L , SR Ca 2؉ Flux, and SR Ca 2؉ Content
Supplemental Table I establishes that contractility in cardiomyocytes isolated from PI3K␥ Ϫ/Ϫ mice was enhanced compared with PI3K␥ ϩ/Ϫ or PI3K␥ ϩ/ϩ mice, consistent with our previous results. 8, 9 To explore the basis for the enhanced contractility, Ca 2ϩ transients were recorded in fieldstimulated cardiomyocytes. Ca 2ϩ transient amplitudes (ie, ratio of indo-1 fluorescence at 405 nm to 495 nm) at 1 Hz stimulation were larger (PϽ0.05), whereas times for 50% relaxation were shorter (PϽ0.05) in PI3K␥ Ϫ/Ϫ (0.209Ϯ0.01 and 175.9Ϯ13.6 ms, nϭ17) compared with PI3K␥ ϩ/Ϫ cardiomyocytes (0.165Ϯ0.01 and 210.98Ϯ9.8 ms, nϭ19) ( Figure  1 ). Similar effects were observed at 3 Hz stimulation ( Figure  1 ). Ca 2ϩ transients in PI3K␥ ϩ/ϩ myocytes were indistinguishable from PI3K␥ ϩ/Ϫ (see Table) .
The previous results show that PI3K␥ Ϫ/Ϫ cardiomyocytes have enhanced Ca 2ϩ cycling. Although I Ca,L is a major determinant of SR Ca 2ϩ release and loading, 20 no increase in I Ca,L amplitude or kinetics ( Figure 2A ) was observed in PI3K␥ Ϫ/Ϫ cardiomyocytes when pipette solutions contained 4 mmol/L EGTA to eliminate Ca 2ϩ transients. Because cell capacitance was similar (Pϭ0.7) between PI3K␥ Ϫ/Ϫ (176.3Ϯ9.9 pF, nϭ14) and PI3K␥ ϩ/Ϫ myocytes (169.4Ϯ12.1 pF, nϭ15), I Ca,L density was unchanged between PI3K␥ Ϫ/Ϫ and PI3K␥ ϩ/Ϫ cardiomyocytes at all voltage ( Figure 2B ). Further, neither the time course of I Ca,L inactivation (ie, fast and slow time constants, 17 data not shown) nor the voltage for 50% steady-state inactivation differed (PϾ0.9) between PI3K␥ Ϫ/Ϫ (Ϫ36.9Ϯ0.2 mV, nϭ15) and PI3K␥ ϩ/Ϫ (Ϫ36.7Ϯ0.1 mV, nϭ14) myocytes.
Modulation of the AP profile as a consequence of K ϩ current changes can also affect cardiomyocyte contractility 21, 22 by altering L-type Ca 2ϩ channel and Na ϩ /Ca 2ϩ exchange function. However, no differences in AP duration (APD) were observed at 50% or 90% repolarization between PI3K␥ Ϫ/Ϫ and PI3K␥ ϩ/Ϫ cardiomyocytes (Figure 2 ; supplemental Table II ) when APs were recorded in the presence of 500 mol/L extracellular CdCl 2 plus 5 mmol/L intracellular EGTA to eliminate Ca 2ϩ transients, blocking I Ca,L , and minimize contributions of I NCX to AP profile. Consistent with these AP measurements, no differences in K ϩ currents (data not shown) and NCX activity (see Figure 4 ) were detected between PI3K␥ Ϫ/Ϫ and PI3K␥ ϩ/Ϫ cardiomyocytes. On the other hand, when I Ca,L and Ca 2ϩ transients were present (achieved by removing Cd 2ϩ and lowering pipette EGTA to 0.05 mmol/L), APD was prolonged at 90% but not 50% repolarization in PI3K␥ Ϫ/Ϫ compared with PI3K␥ ϩ/Ϫ cardiomyocytes (supplemental Table II ), as expected with increased Ca 2ϩ transients. 16, [22] [23] [24] [25] To further investigate the cellular basis for elevated contractility in PI3K␥ Ϫ/Ϫ cardiomyocytes, Ca 2ϩ transients were recorded simultaneously with I Ca,L under voltage-clamp conditions ( Figure 3A ). As in field stimulated myocytes, Ca 2ϩ transient amplitudes were elevated at all voltages tested ( Figure 3B ); at 0 mV the amplitudes in PI3K␥ Ϫ/Ϫ (0.35Ϯ0.05, nϭ12) were larger (PϽ0.01) than either PI3K␥ ϩ/Ϫ (0.17Ϯ0.04, nϭ9) or PI3K␥ ϩ/ϩ (0.17Ϯ0.02, nϭ10) mice. Moreover, Ca 2ϩ transients in PI3K␥ Ϫ/Ϫ cardiomyocytes had reduced (PϽ0.05) decay times without differences in time to peak in association with reduced (PϽ0.01) time constants for fast inactivation of I Ca,L , (which is linked to Ca 2ϩ -mediated inactivation 26 ) at 0 mV (Table) as well as at other voltages (data not shown). Despite altered inactivation, peak I Ca,L densities did not differ between PI3K␥ Ϫ/Ϫ and PI3K␥ ϩ/Ϫ or PI3K␥ ϩ/ϩ myocytes, regardless of voltage ( Figure 3C ). Because Ca 2ϩ transients were elevated without major changes in I Ca,L , ECC gain, which is estimated by dividing the rate of release of the Ca 2ϩ transient (see legend for Figure 3C ) by the time integral of I Ca,L , 17 was markedly enhanced in PI3K␥ Ϫ/Ϫ compared with PI3K␥ ϩ/Ϫ or PI3K␥ ϩ/ϩ ( Figure 3D) .
Differences in Ca 2ϩ transient amplitudes and kinetics seen in PI3K␥ Ϫ/Ϫ cardiomyocytes could originate from modifications in amount and time course of SR Ca 2ϩ release 16 or from alterations in SR Ca 2ϩ uptake rates or both. To directly examine the SR Ca 2ϩ release process, Ca 2ϩ spikes 16 were measured using the technique of Song et al 27 wherein cytosolic Ca 2ϩ levels were clamped with high concentrations of Ca 2ϩ buffers to known levels. Figure 4A shows typical Ca 2ϩ spikes recordings in a PI3K␥ Ϫ/Ϫ and a PI3K␥ ϩ/Ϫ myocyte obtained by spatially averaging the fluo-5N fluorescence across the cell following a step depolarization to 0 mV. Figure 4B establishes that SR Ca 2ϩ spike peaks were increased (PϽ0.01) in PI3K␥ Ϫ/Ϫ (0.57Ϯ0.04, nϭ7) compared with PI3K␥ ϩ/Ϫ (0.41Ϯ0.03, nϭ9) cardiomyocytes, as were the Ca 2ϩ spike integrals for PI3K␥ Ϫ/Ϫ (7.8Ϯ0.5, nϭ7) versus PI3K␥ ϩ/Ϫ (6.0Ϯ0.4, nϭ9), consistent with elevated Ca 2ϩ transients and ECC gains. On the other hand, no changes were observed in the time to peak of Ca 2ϩ spikes for PI3K␥ Ϫ/Ϫ (7.9Ϯ0.6 ms, nϭ7) versus PI3K␥ ϩ/Ϫ (8.1Ϯ0.5 ms, nϭ9), demonstrating that SR Ca 2ϩ release kinetics were not affected by PI3K␥ ablation.
The previous results suggest enhanced PI3K␥ Ϫ/Ϫ myocyte contractility originates from increased SR Ca 2ϩ uptake rates leading to elevated SR Ca 2ϩ contents. To test this hypothesis, myocytes were dialyzed with solutions containing 0.05 mol/L fluo-3 and stimulated at 1 Hz with 8 steps from Ϫ80 to ϩ10 mV for 100 ms (see Methods) to allow steady state loading of the SR with Ca 2ϩ . The myocytes were then superfused with 20 mmol/L caffeine to release Ca 2ϩ from the SR which is extruded by forward mode NCX activity (I NCX ). 28 Figure 4 shows that time integral of I NCX (proportional to SR Ca 2ϩ content) was increased (PϽ0.05) in PI3K␥ Ϫ/Ϫ (1.64Ϯ0.4 pC/pF, nϭ14) compared with PI3K␥ ϩ/Ϫ cardiomyocytes (1.01Ϯ0.1 pC/pF, nϭ12). By contrast, decay times for caffeine-induced I NCX did not differ between PI3K␥ Ϫ/Ϫ (1368.0Ϯ299.4 ms) and PI3K␥ ϩ/Ϫ cardiomyocytes (1332.0Ϯ196.1 ms), establishing that I NCX densities were not detectably altered by PI3K␥ ablation. 19 
cAMP Inhibition
The previous results are entirely consistent with recent studies showing that cAMP 7-9,29 levels and PLN phosphorylation are increased in PI3K␥-deficient cardiomyocytes. 8, 9 To test whether elevated cAMP was responsible for increased Ca 2ϩ transients and contractility in PI3K␥ Ϫ/Ϫ mice, we dialyzed myocytes with 100 mol/L adenosine-3Ј, 5Ј cyclic phosphorothioate (Rp-cAMP), a cAMP antagonist. Figure 4 shows that Rp-cAMP had no effect on Ca 2ϩ spikes integrals (Ύ⌬F/F 0 ) in PI3K␥ ϩ/Ϫ myocytes while eliminating the differences between PI3K␥ Ϫ/Ϫ (6.21Ϯ0.4, nϭ9) and PI3K␥ ϩ/Ϫ (6.27Ϯ0.4, nϭ7) cardiomyocytes. Dialysis with Rp-cAMP also completely abolished increased SR Ca 2ϩ content in PI3K␥ Ϫ/Ϫ (0.77Ϯ0.1 pC/pF, nϭ15) versus PI3K␥ ϩ/Ϫ (0.75Ϯ0.1 pC/pF, nϭ13) cardiomyocytes while having no effect on the SR Ca 2ϩ content in PI3K␥ ϩ/Ϫ (Figure 4) . Additionally, Rp-cAMP dialysis reduced the amplitude while slowing the kinetics of Ca 2ϩ transients in PI3K␥ Ϫ/Ϫ to the baseline levels observed in PI3K␥ ϩ/Ϫ cardiomyocytes with or without Rp-cAMP (Table) . These effects on SR Ca 2ϩ content and release as well as Ca 2ϩ transients were not caused by changes in I Ca,L because Rp-cAMP had no effect on I Ca,L in either PI3K␥ Ϫ/Ϫ or PI3K␥ ϩ/Ϫ cardiomyocytes (Table) . However, in the presence of Ca 2ϩ transients, cAMP inhibition eliminated differences in Ca 2ϩ -dependent inactivation of I Ca,L to control values in PI3K␥ Ϫ/Ϫ mice (Table) , suggesting that accelerated inactivation of I Ca,L was secondary to increased Ca 2ϩ transients.
␤-Adrenergic Stimulation
The previous results establish that increases in SR Ca 2ϩ content and release in mice lacking PI3K␥ are mediated by cAMP. Because cAMP is typically regulated in myocardium by ␤-adrenergic signaling, we examined the effects of the ␤-adrenergic agonist isoproterenol (1 mol/L). Figure 5 shows that application of isoproterenol increased I Ca,L amplitude and accelerate I Ca,L inactivation to the same extent in PI3K␥ Ϫ/Ϫ and PI3K␥ ϩ/Ϫ cardiomyocytes (as well as PI3K␥ ϩ/ϩ ; Table) . Although not shown, the voltage dependence of peak I Ca,L was shifted in hyperpolarized directions as expected with ␤-adrenergic stimulation in all 3 groups of mice. Isoproterenol application also increased Ca 2ϩ transients in both PI3K␥ Ϫ/Ϫ and PI3K␥ ϩ/Ϫ myocytes by about the same relative amount ( Figure 5A and 5C) . As a result, Ca 2ϩ transients remained elevated and still showed more rapid relaxation kinetics in PI3K␥ Ϫ/Ϫ versus PI3K␥ ϩ/Ϫ myocytes with isoproterenol (Table) . Taken together, these results suggest that PI3K␥ limits the extent of cAMP elevations in the vicinity of the SR after the stimulation of adenylate cyclase, consistent with its role as an activator of PDE3B in cardiomyocytes. 9
Discussion
Our results establish that loss of PI3K␥ leads to the increase in cardiomyocyte shortening, Ca 2ϩ transients, SR Ca 2ϩ release flux, and SR Ca 2ϩ load along with enhanced rates of Ca 2ϩ transient relaxation and acceleration of Ca 2ϩ -mediated I Ca,L inactivation. These functional effects of PI3K␥ ablation were completely abolished by cAMP antagonism using Rp-cAMP. The cAMP-mediated enhancements of cardiac ECC in PI3K␥ Ϫ/Ϫ myocytes were not, however, associated with changes in other factors regulating ECC, such as K ϩ currents, APD, and I Ca,L , when Ca 2ϩ transients were suppressed in these and Ca 2ϩ transients (right) recorded simultaneously at 0 mV before (C) and after isoproterenol (ISO, 1 mol/L) application in a PI3K␥ Ϫ/Ϫ and a PI3K␥ ϩ/Ϫ cardiomyocyte. Dotted lines represent 0 current levels for I Ca,L traces and a fluorescence ratio of 1 for F/F 0 . B, Mean I Ca,L peak amplitude measured at 0 mV in PI3K␥ Ϫ/Ϫ (black, nϭ9) and PI3K␥ ϩ/Ϫ (white, nϭ8) cardiomyocytes before and after isoproterenol treatment. C, Mean Ca 2ϩ transient peak amplitude measured simultaneously with I Ca,L at 0 mV in PI3K␥ Ϫ/Ϫ and PI3K␥ ϩ/Ϫ cardiomyocytes before and after isoproterenol treatment;
†PϽ0.01 (same groups), *PϽ0.01 (between groups).
myocytes. Collectively, these findings strongly suggest that increases in SR Ca 2ϩ uptake rates and loads, as a result of subcellular elevations of cAMP in the vicinity of the SR, are responsible for increased contractility in cardiomyocytes lacking PI3K␥. 8, 9, 29 This conclusion is consistent with previous studies showing increased cAMP levels [7] [8] [9] 29 and PLN phosphorylation 8, 9 in PI3K␥ Ϫ/Ϫ myocardium. It is conceivable that cAMP-dependent alterations in SR Ca 2ϩ release channels also occur and contribute to the increased contractility in PI3K␥ Ϫ/Ϫ hearts, although no changes in kinetics of SR Ca 2ϩ release fluxes (ie, Ca 2ϩ spikes) were observed in our studies. The regulation of cardiac contractility appears to be unique to the PI3K␥ isoform because contractile strength of hearts is unchanged in mice with dominant-negative suppression of PI3K␣. 8 Furthermore, PI3K␣ and PI3K␤ protein expression, the 2 other main cardiac isoforms in total heart extracts, were unchanged in PI3K␥ Ϫ/Ϫ compared with PI3K␥ ϩ/Ϫ mice, 8 suggesting that compensatory changes in these isoforms are not responsible for the elevated contractility seen in PI3K␥deficient mice. Despite clear reliance of elevated SR Ca 2ϩ cycling on cAMP, PI3K␥ Ϫ/Ϫ did not have elevated I Ca,L . These observations were surprising because L-type Ca 2ϩ channels are a prototype for cAMP-PKA regulation and because a previous study showed that PI3K inhibitors reduced I Ca,L in rat neonatal cardiomyocytes. 30 Differences between our adult mouse cardiomyocyte studies and previous rat neonatal cardiomyocyte studies are unclear but may be related to the underdevelopment of the SR and T-tubule system in neonatal cardiac myocytes compared with adult myocytes, 31 although nonspecific actions of PI3K inhibitors might also contribute. 4, 32 Regardless, the differential effects of PI3K␥ ablation on SR Ca 2ϩ function versus I Ca,L establishes that PI3K␥ is a critical negative-regulator of cAMP-PKA signaling in microdomains, including the SR within the cardiomyocytes.
The mechanism whereby PI3K␥ regulates cAMP levels in the vicinity of the SR (or in other microdomains of cells) is not entirely clear. 33 In transgenic mice with cardiac-specific overexpression of human AC type 8 cardiac, contractility was increased in association with elevated Ca 2ϩ transients and accelerated relaxation but without any alteration of I Ca,L amplitude caused by a rearrangement of PDE isoforms leading to a strong compartmentation of cAMP. 34 In addition, previous studies have established that subcellular compartmentation of cAMP and PKA signaling in cardiomyocytes depends on regional expression of PDEs. 35 More recently, studies showed that PI3K␥ stimulates PDE3B isoform by direct protein-protein interactions, independent of PIP 3 generation. 9 This finding is consistent with previous results showing a lack of effect of PI3K inhibitors on contractility and Ca 2ϩ transients in wild-type mice, 32, 36 suggesting that the enzymatic generation of PIP 3 is not required for the local regulation of cAMP levels by PI3K␥. Thus, it appears that PI3K␥ regulates cardiomyocyte contractility and Ca 2ϩ transients by directly inhibiting PDE3B and thereby cAMP-PKA signaling in subcellular compartments containing the SR. The absence of I Ca,L elevations in PI3K␥ Ϫ/Ϫ mice suggest that another PDE isoform may regulate cAMP in the vicinity of L-type Ca 2 channels. Interestingly, connections between PDE3B and PI3K leading to the regulation of cAMP and the control of insulin secretion have been previously reported in pancreatic ␤-cells. 37, 38 However, a previous study in myocytes has suggested that localization of cAMP-PKA signaling involves the localized regulation of protein phosphatase activity by PI3K. 6 On the other hand, mice lacking the lipid phosphatase PTEN have elevated cardiac PIP 3 levels along with reduced contractility, supporting the concept that elevated PIP 3 levels can inhibit cardiac contractility. 8 Clearly, further studies are necessary to fully dissect the molecular mechanisms underlying the subcellular compartmentation of cAMP regulation by PI3K␥.
Compartmentation of cAMP-PKA signaling in cardiomyocytes has also been hypothesized to help to explain the differential actions of ␤2-adrenergic stimulation on contractility versus I Ca,L 39,40 (reviewed by Steinberg and Brunton 41 ). Specifically, the acute application of PI3K inhibitors permits ␤2-adrenergic stimulation to increase PLN phosphorylation and Ca 2ϩ transients amplitude, independent of elevations in cAMP levels, presumably as a consequence of inhibiting the enzymatic activity of the PI3K␥ isoform. 6 Further studies are clearly warranted to determine the possible role of PI3K␥ and its interaction with PDEs in mediating these ␤2-adrenergic actions. It has also been recently shown that inhibition of PI3K with LY294002 significantly enhances ␤1-adrenergicinduced increases in I Ca,L , Ca 2ϩ transients, and cardiomyocytes contractility. 36 In our studies, ␤-adrenergic stimulation increased I Ca,L amplitude and shifted the current-voltage relationships leftward to the same extent (from the same baseline) in PI3K␥ Ϫ/Ϫ myocytes compared with control. ␤-Adrenergic stimulation also increased Ca 2ϩ transient amplitudes and abbreviated relaxation kinetics in PI3K␥ Ϫ/Ϫ and control cardiomyocytes, but Ca 2ϩ transients remained elevated with faster kinetics in PI3K␥ Ϫ/Ϫ myocytes after isoproterenol treatment. These findings suggest that cAMP levels are submaximally elevated in the SR-containing microdomains of PI3K␥ Ϫ/Ϫ cardiomyocytes and that PI3K␥ limits the response of cardiomyocytes to ␤-adrenergic at the level of SR, consistent with PI3K␥'s ability to activate PDE3B. 9 Although K ϩ currents and APDs (in the absence of Ca 2ϩ transients) were unchanged in PI3K␥-deficient mice, APD 90 was prolonged without changes in APD 50 when Ca 2ϩ transients were present. The precise origin of this AP prolongation is not obvious because during this phase of the AP there is a complex, delicate, and dynamic interaction between depolarizing currents, like I NCX and I Ca,L , whose activities are tightly regulated by intracellular Ca 2ϩ levels and repolarizing K ϩ currents. Based on previous studies, 42, 43 it seems likely that this prolongation originates largely from increased depolarizing I NCX as a result of elevated Ca 2ϩ transients, despite the absence of evidence for increased I NCX transport densities in the PI3K␥ Ϫ/Ϫ (as assessed from the rate of decay of the caffeine-induced I NCX ). On the other hand, although the prolonged APD tends to increase the total Ca 2ϩ entry through L-type Ca 2ϩ channels, 21 differences in I Ca,L are unlikely to be responsible for the increased APD, because I Ca,L densities (assessed in the absence of Ca 2ϩ transients) are unaffected by PI3K␥ ablation. In fact, the rate of I Ca,L inactivation was accelerated in PI3K␥ Ϫ/Ϫ mice, because of elevated Ca 2ϩ transients, 44 when Ca 2ϩ transients were present, which would reduce the depolarizing effects of I Ca,L . Finally, it should be mentioned that the observed APD prolongation will indirectly influence the SR load in PI3K␥ Ϫ/Ϫ myocytes by modulating the net Ca 2ϩ transported by the NCX and I Ca,L during each cardiac cycle in a dynamic manner, as summarized in previous studies. 44 Thus, whereas many factors are likely to complexly modulate SR Ca 2ϩ content in PI3K␥ Ϫ/Ϫ myocytes, the origin of these changes can ultimately be traced to cAMP-dependent increases in SR Ca 2ϩ uptake which in turn affects other Ca 2ϩ dependent processes.
A prominent feature of myocardium from diseased hearts is the reduction of Ca 2ϩ transients as a result of decreased SR Ca 2ϩ load without changes in I Ca,L density. [45] [46] [47] [48] This pattern is opposite of that seen in our PI3K␥ Ϫ/Ϫ mice, suggesting that increased PI3K␥ activity may conceivably contribute to the alterations in heart contraction observed in several pathologies 7,8,10 -12,49 by differentially reducing cAMP levels and thereby PKA signaling at the level of the SR. This suggestion is consistent with previous studies showing that PI3K␥ activity and expression are increased in cardiac disease. 9, 49 Interestingly, PDE3 and PDE4 gene expression and activities are also enhanced in heart failure. 50 Increased PI3K␥ in association with increased activity of selected PDE could be expected to work in conjunction with reduced SERCA2a expression to reduce SR Ca 2ϩ uptake, leading to impaired Ca 2ϩ handling and contractility observed in heart disease. 48 Clearly, future studies will be required to fully assess the contribution of changes in local cAMP signaling to changes seen in heart disease.
In summary, our results establish that the loss of PI3K␥ leads to increased contractility and Ca 2ϩ transients as a result of elevations in SR Ca 2ϩ loading. This enhanced contractility likely involves localized elevations of cAMP-PKA signaling and increased PLN phosphorylation at the level of the SR as a result of decreased PDE actions. The PI3K␥-dependent regulation of contractility by the SR could be an important contributor to the functional changes observed in heart disease.
